Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Track 1

Hugo Gutierrez de Teran's Biography



Hugo Gutierrez de Teran, Senior Researcher, Uppsala University

• PhD in Health Sciences and Molecular modeling (Pompeu Fabra University, Barcelona, 2004, with Ferran Sanz).
• Postdoctoral fellow: Uppsala University (2006-08, with Johan Åqvist)
• Head, Bioinformatics Unit 2007-2012 (Public Foundation of Genomic Medicine of Galicia, Santiago University Hospital, Spain),
• Visiting researcher, The Scripps Research institute (2012, with Ray Stevens).
• Senior researcher, Uppsala University (2013-present)

Since my PhD I have specialized in Computational Chemistry and Structural Bioinformatics, mostly applied to Drug Design projects, including several collaborations with the pharmaceutical industry. I have co-authored almost 50 scientific publications, including reviews and book chapters. I am actually leading a team of 7 people (4 postdocs), mainly devoted to the characterization and ligand design of G-protein coupled receptors (see http://gpcr-modsim.org). We are also deeply interested on the use of free energy calculations in drug design and biochemical characterization of biological targets. In this presentation I will focus on our recent efforts in introducing free energy calculations in the characterization of GPCRs, and present some successful examples of computer-aided ligand design in this field.

Hugo Gutierrez de Teran Image

Computational Modeling and Simulation of GPCRs in Structure-Based Drug Design

Wednesday, 18 June 2014 at 11:00

Add to Calendar ▼2014-06-18 11:00:002014-06-18 12:00:00Europe/LondonComputational Modeling and Simulation of GPCRs in Structure-Based Drug DesignSELECTBIOenquiries@selectbiosciences.com

The superfamily of G-protein-coupled receptors (GPCRs) is particularly relevant in pharmacology. I will present a specific methodology for modelling and simulation of GPCRs implemented in the web-based server GPCR-ModSim (http://gpcr.usc.es) and a new efficient technique for quantitative predictions of the effects of single point-mutations on ligand binding. I will illustrate these methods with recent applications on ligand binding to adenosine and neuropeptide-Y receptors.


Add to Calendar ▼2014-06-17 00:00:002014-06-18 00:00:00Europe/LondonTrack 1SELECTBIOenquiries@selectbiosciences.com